SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-16-142983
Filing Date
2016-09-02
Accepted
2016-09-02 16:36:27
Documents
6
Period of Report
2016-07-22
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a16-17890_18ka.htm 8-K/A 47685
2 EX-23.1 a16-17890_1ex23d1.htm EX-23.1 2914
3 EX-99.1 a16-17890_1ex99d1.htm EX-99.1 267022
4 EX-99.2 a16-17890_1ex99d2.htm EX-99.2 247875
5 EX-99.3 a16-17890_1ex99d3.htm EX-99.3 263519
6 EX-99.4 a16-17890_1ex99d4.htm EX-99.4 89304
  Complete submission text file 0001104659-16-142983.txt   919470
Mailing Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034
Business Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034 610-527-6790
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33277 | Film No.: 161869086
SIC: 2834 Pharmaceutical Preparations